Dr. Jeffrey Lancet published in Journal of Hematology & Oncology "Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML" https://t.co/XK7f
4,201 followers
3,720 followers
Our publication on a Quality‑adjusted Time Without Symptoms of disease or Toxicity (Q‑TWiST) analysis with CPX-351 vs 3+7 just published, further showing benefits of this approach in patients with secondary AML. https://t.co/G5wEhEANaF
925 followers
New article: Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML https://t.co/yYj2QUkdXB #AML #leusm #hematology https://t.co/AiKbg45men